Incorporating hematopoietic stem-cell transplantation after second-line carfilzomib-lenalidomide-dexamethasone (KRd)

Byun, JM; Yoon, SS; Koh, Y; Min, CK; Lee, JH; Jo, J; Park, H; Lee, J; Kang, KW; Lee, Y

Yoon, SS (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, 101 Daehak Ro, Seoul 03080, South Korea.; Yoon, SS (corresponding author), Seoul Natl Univ, Canc Res Inst, Seoul, South Korea.; Yoon, SS (corresponding author), Seoul Natl Univ Hosp, Ctr Med Innovat, Biomed Res Inst, Seoul, South Korea.

THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020; 11 ():

Abstract

Background: Traditionally believed to be an integral part of multiple myeloma (MM) treatment, the role of hematopoietic stem-cell transplantation (HSC......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索